ChemLifeIntel/Companies/Central Admixture Pharmacy Services, Inc.

Central Admixture Pharmacy Services, Inc.

HIGH RISKHQ: — · Private · Founded —

LISTINGPrivateFOUNDED0

FOCUS THERAPY AREAS

Manufacturer

COMPANY INTELLIGENCE SNAPSHOTlive

Manufacturing Sites

Intelligence Briefs

Active Regulatory Actions

—

HQ Country

ACTIVE REGULATORY RISK1 active regulatory action on record · HQ · monitored across 12 manufacturing sites

View regulatory detail

INTELLIGENCE

Showing 3 of 3 briefs on Central Admixture Pharmacy Services, Inc.

REGULATORY INTELLIGENCE·Recall

CAPS Los Angeles Recalls TPN Bag Due to Missing Insulin: Critical Implications for Compounding Pharmacy Quality

Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles initiated a Class II recall for a patient-specific TPN bag due to incorrect formulation, specifically the omission of insulin. This event, originating from their Santa Fe Springs, CA facility, highlights critical quality control vulnerabilities in compounding pharmacies. Procurement and regulatory teams must rigorously vet specialized suppliers to mitigate risks associated with essential, patient-tailored medications.

90-Day Activity

Central Admixture Pharmacy Services,TPN bag (patient specific)

PSPriya Subramaniam· Intelligence Analyst

2026-05-13

REGULATORY INTELLIGENCE·Recall

FDA Recall Highlights Critical Documentation Lapses in Sterile Compounding at Central Admixture Pharmacy Services, Inc. Los Angeles

Central Admixture Pharmacy Services, Inc. (CAPS) Los Angeles initiated a Class II recall for Peripheral Parenteral Nutrition due to insufficient documentation of daily cleaning in an ISO-5 sterile compounding area. This event underscores the critical need for robust processing controls and meticulous record-keeping in sterile drug manufacturing, impacting procurement and regulatory strategies for compounded preparations. Healthcare providers must verify supplier compliance to mitigate patient risk.

90-Day Activity

Central Admixture Pharmacy Services,

PSPriya Subramaniam· Intelligence Analyst

2025-07-23

REGULATORY INTELLIGENCE·Warning Letter

FDA Class I Recall: Central Admixture Pharmacy Services' PHENYLephrine Contamination Poses Nationwide Risk

Central Admixture Pharmacy Services, Inc. initiated a Class I recall for 1,546 bags of PHENYLephrine due to particulate matter, distributed nationwide. This poses a critical patient safety risk and immediate supply chain challenge for healthcare providers. Procurement and regulatory teams must assess current inventory and diversify sourcing for this essential vasopressor.

90-Day Activity

Central Admixture Pharmacy Services,PhenylephrineHSN 3004.90.90

MKMeera Krishnan· Senior Regulatory Intelligence Analyst

2025-03-19 Warning Letter